» Articles » PMID: 10893363

Cystic Fibrosis. End-stage Care in Canada

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2000 Jul 14
PMID 10893363
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the circumstances in which individuals with cystic fibrosis (CF) die, the role of different caregivers, and the extent of palliative care for CF patients.

Design: Mailed survey of CF physicians.

Setting: CF centers in Canada.

Patients: All CF deaths in 1996 known to centers in Canada.

Results: The mean age (+/- SD) at death of the 45 individuals included in the study was 25.8 +/- 13.5 years. The major cause of death was respiratory (34 patients; 75.5%). Nutritional concerns were common. Lung transplantation was considered in 42 patients (93.2%), with 7 patients (17.1%) being entered on a list, but it was carried out in only 2 patients (4.4%). Autopsies were performed on only 10 patients (22.2%). Most patients died in hospital (37 patients; 82.2%), and 7 patients (15.6%) died in ICUs while receiving intermittent positive-pressure ventilation. Palliative care was never discussed in 10 patients (25%). In a further 16 patients (40%), it was not discussed until the last month before death.

Conclusions: Respiratory disease remains the most common cause of death in CF patients. Lung transplantation is frequently considered, but most patients die without having had a transplant. Discussions on end-of-life care could be considered sooner.

Citing Articles

Improving end-of-life care for adults with cystic fibrosis: an improvement project.

Cathcart F, Wood J, Madge S BMJ Open Qual. 2020; 9(3).

PMID: 32747389 PMC: 7401994. DOI: 10.1136/bmjoq-2019-000861.


Palliative care skills in CF: Perspectives of adults with CF, caregivers, and CF care team members.

Trandel E, Kavalieratos D, Basile M, Hobler M, Georgiopoulos A, Chen E Pediatr Pulmonol. 2020; 55(8):2017-2024.

PMID: 32384215 PMC: 8597706. DOI: 10.1002/ppul.24806.


Palliative Care Needs of Individuals with Cystic Fibrosis: Perspectives of Multiple Stakeholders.

Dellon E, Basile M, Hobler M, Georgiopoulos A, Chen E, Goggin J J Palliat Med. 2020; 23(7):957-963.

PMID: 32023421 PMC: 8255308. DOI: 10.1089/jpm.2019.0464.


An overview of end-of-life issues in the intensive care unit.

Papadimos T, Maldonado Y, Tripathi R, Kothari D, Rosenberg A Int J Crit Illn Inj Sci. 2012; 1(2):138-46.

PMID: 22229139 PMC: 3249847. DOI: 10.4103/2229-5151.84801.


Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis.

Dellon E, Shores M, Nelson K, Wolfe J, Noah T, Hanson L J Pain Symptom Manage. 2010; 40(6):821-8.

PMID: 20828981 PMC: 3762977. DOI: 10.1016/j.jpainsymman.2010.03.021.